Krka Nine-Monthly Sales up 16%

Novo Mesto, 10 October - Drug maker Krka said Monday its sales were up 16% to SIT 98.2bn (EUR 410m) in the first three quarters of this year. Although the company failed to reveal profits for the third quarter, chairman Anton Colaric said the company was expecting to finish the year with a profit of SIT 20bn (EUR 83.47), which would be around 35% more than last year.